241 – 250 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.
(
- Contribution to journal › Article
-
Mark
Genetic risk factors for inhibitors in haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease
(
- Contribution to journal › Article
-
Mark
Warfarin treatment complications do not correlate to cTTR when above 70.
(
- Contribution to journal › Article
-
Mark
Inhibitors in haemophilia: what have we learned from registries? A systematic review.
(
- Contribution to journal › Scientific review
-
Mark
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
(
- Contribution to journal › Article
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
(
- Contribution to journal › Scientific review
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
(
- Contribution to journal › Scientific review
-
Mark
Zinc is the modulator of the calcium-dependent activation of post-translationally acting thiol-enzymes in autoimmune diseases.
(
- Contribution to journal › Article